Stefanie Stein

Therapeutic targeting of the PLK1-PRC1-axis triggers cell death in genomically silent childhood cancer

Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma

MHC Class I-Restricted TCR-Transgenic CD4+ T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In Vivo

Publisher Correction: Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma

Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes

Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma

Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients

Integrative clinical transcriptome analysis reveals <i>TMPRSS2‐ERG</i> dependency of prognostic biomarkers in prostate adenocarcinoma

Oncogenic hijacking of a developmental transcription factor evokes therapeutic vulnerability for ROS-induction in Ewing sarcoma

Biomarker-based outcome prediction in prostate adenocarcinoma depends on the <i>TMPRSS2-ERG</i> status

Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma

Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma

Targeting the CALCB/RAMP1-axis inhibits growth of Ewing sarcoma

Cooperation of dominant oncogenes with regulatory germline variants shapes clinical outcomes in childhood cancer